Literature DB >> 23967720

Calciphylaxis: a rare complication in alcoholic liver disease.

E Sermijn1, T Strobbe, L Vandekerckhove, L Libbrecht, I Colle, R Schoonjans, D Vogelaers.   

Abstract

Calciphylaxis, or calcific uremic arteriolopathy (CUA) is a rare but well described entity in patients with endstage renal disease (ESRD) and/or hyperparathyroidism. CUA is characterized by systemic acute calcification of the small and intermediate dermal vasculature that can lead to epidermal ischemia, ulceration, and necrosis. Cutaneous lesions of calciphylaxis characteristically begin as tender, violaceous, livedoid discolorations. The mechanisms of disease remain poorly understood although abnormal bone and mineral metabolism and hyperparathyroidism can contribute to CUA. Therapeutic strategies are of unproven benefit and mortality remains high. Calciphylaxis has also been extremely rarely reported in patients without ESRD and/or hyperparathyroidism. We report an unusual case of calciphylaxis in a patient with alcoholic liver cirrhosis and normal renal function, without any alteration in the phosphocalcic and parathyroid hormone (PTH) metabolisms.

Entities:  

Mesh:

Year:  2013        PMID: 23967720     DOI: 10.2143/ACB.2863

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  2 in total

1.  Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis.

Authors:  Sagar U Nigwekar; Donald B Bloch; Rosalynn M Nazarian; Cees Vermeer; Sarah L Booth; Dihua Xu; Ravi I Thadhani; Rajeev Malhotra
Journal:  J Am Soc Nephrol       Date:  2017-01-03       Impact factor: 10.121

Review 2.  POEMS syndrome and calciphylaxis: an unrecognized cause of abnormal small vessel calcification.

Authors:  Nobuyuki Araki; Sonoko Misawa; Kazumoto Shibuya; Satoshi Ota; Takashi Oide; Asuka Kawano; Minako Beppu; Yukio Nakatani; Satoshi Kuwabara
Journal:  Orphanet J Rare Dis       Date:  2016-04-12       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.